Literature DB >> 15300468

Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms.

Elisabetta Danieli1, Paolo Airò, Lorenzo Bettoni, Massimo Cinquini, Chiara M Antonioli, Ilaria Cavazzana, Franco Franceschini, Roberto Cattaneo.   

Abstract

The aim of this study was to evaluate health-related quality of life (HR-QOL) in patients with systemic sclerosis (SSc), to compare it with that of patients with rheumatoid arthritis (RA), and to correlate it with other parameters. HR-QOL was evaluated by the Short Form 36 (SF-36), SSc disease activity and severity by preliminary indexes recently proposed, disability by the Health Assessment Questionnaire (HAQ), and depressive symptoms by the Beck Depression Inventory. HR-QOL perception was not statistically different in patients with SSc and RA, except that patients with diffuse cutaneous involvement had worse scores in the general health and mental health dimensions than patients with RA (p=0.03). Compared with RA, patients with SSc tended to perceive less bodily pain (p=0.06) and have less disability (p=0.04) but to report higher depressive symptom scores (p=0.05). SSc patients' HR-QOL was associated with some disease severity scales (general, kidney and, less significantly, heart), but it was poorly correlated with the other evaluated disease activity and severity indexes. A strong correlation with disability and with depressive symptoms was observed. In conclusion, patients with SSc perceived a reduced HR-QOL similar to that of patients with RA. SF-36 may provide useful information in their evaluation.

Entities:  

Mesh:

Year:  2004        PMID: 15300468     DOI: 10.1007/s10067-004-0970-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  33 in total

1.  Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

Authors:  D M van der Heijde; M A van 't Hof; P L van Riel; L A Theunisse; E W Lubberts; M A van Leeuwen; M H van Rijswijk; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

2.  Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus.

Authors:  D Da Costa; P L Dobkin; M A Fitzcharles; P R Fortin; A Beaulieu; M Zummer; J L Senécal; J R Goulet; E Rich; D Choquette; A E Clarke
Journal:  J Rheumatol       Date:  2000-02       Impact factor: 4.666

3.  Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the Short Form-36 (SF-36) in a community and a clinic based sample.

Authors:  N J Wiles; D G Scott; E M Barrett; P Merry; E Arie; K Gaffney; A J Silman; D P Symmons
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

4.  Health related quality of life in a population sample with arthritis.

Authors:  C L Hill; J Parsons; A Taylor; G Leach
Journal:  J Rheumatol       Date:  1999-09       Impact factor: 4.666

5.  A disease severity scale for systemic sclerosis: development and testing.

Authors:  T A Medsger; A J Silman; V D Steen; C M Black; A Akesson; P A Bacon; C A Harris; S Jablonska; M I Jayson; S A Jimenez; T Krieg; E C Leroy; P J Maddison; M L Russell; R K Schachter; F A Wollheim; H Zacharaie
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

6.  The impact of pain and symptoms of depression in scleroderma.

Authors:  Lisa M Benrud-Larson; Jennifer A Haythornthwaite; Leslie J Heinberg; Christy Boling; Jeffrey Reed; Barbara White; Fredrick M Wigley
Journal:  Pain       Date:  2002-02       Impact factor: 6.961

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

8.  The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time.

Authors:  V D Steen; T A Medsger
Journal:  Arthritis Rheum       Date:  1997-11

9.  Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years.

Authors:  L Bettoni; A Geri; P Airò; E Danieli; I Cavazzana; C Antonioli; L Chiesa; F Franceschini; A Grottolo; A Zambruni; E Radaeli; R Cattaneo
Journal:  Clin Rheumatol       Date:  2002-06       Impact factor: 2.980

10.  Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures.

Authors:  T K Kvien; S Kaasa; L M Smedstad
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

View more
  35 in total

1.  Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort.

Authors:  Roozbeh Sharif; Maureen D Mayes; Perry M Nicassio; Emilio B Gonzalez; Hilda Draeger; Terry A McNearney; Rosa M Estrada-Y-Martin; Deepthi K Nair; John D Reveille; Frank C Arnett; Shervin Assassi
Journal:  Semin Arthritis Rheum       Date:  2011-03-22       Impact factor: 5.532

2.  Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ).

Authors:  Luiza F Rocha; Roberta G Marangoni; Percival D Sampaio-Barros; Mauricio Levy-Neto; Natalino H Yoshinari; Eloisa Bonfa; Virginia Steen; Sergio C Kowalski
Journal:  Clin Rheumatol       Date:  2013-08-22       Impact factor: 2.980

3.  Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients.

Authors:  T A McNearney; H S Sallam; S E Hunnicutt; D Doshi; D E Wollaston; M D Mayes; J D Z Chen
Journal:  Neurogastroenterol Motil       Date:  2009-06-30       Impact factor: 3.598

4.  New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).

Authors:  Brett D Thombs; Lisa R Jewett; Shervin Assassi; Murray Baron; Susan J Bartlett; Angela Costa Maia; Ghassan El-Baalbaki; Daniel E Furst; Karen Gottesman; Jennifer A Haythornthwaite; Marie Hudson; Ann Impens; Annett Korner; Catarina Leite; Maureen D Mayes; Vanessa L Malcarne; Sarosh J Motivala; Luc Mouthon; Warren R Nielson; Diane Plante; Serge Poiraudeau; Janet L Poole; Janet Pope; Maureen Sauve; Russell J Steele; Maria E Suarez-Almazor; Suzanne Taillefer; Cornelia H van den Ende; Erin Arthurs; Marielle Bassel; Vanessa Delisle; Katherine Milette; Allison Leavens; Ilya Razykov; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

5.  Assessment of fatigue and its relationships with disease-related parameters in patients with systemic sclerosis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Rachida Bensabbah; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2011-12-21       Impact factor: 2.980

6.  Measuring illness behavior in patients with systemic sclerosis.

Authors:  Erin L Merz; Vanessa L Malcarne; Scott C Roesch; Roozbeh Sharif; Brock E Harper; Hilda T Draeger; Emilio B Gonzalez; Deepthi K Nair; Terry A McNearney; Shervin Assassi; Maureen D Mayes
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

7.  Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders.

Authors:  Thomas Hyphantis; Barbara Tomenson; Vassiliki Paika; Augoustina Almyroudi; Chrisavgi Pappa; Niki Tsifetaki; Paraskevi V Voulgari; Alexandros A Drosos; Nicholas Pavlidis; Francis Creed
Journal:  Qual Life Res       Date:  2009-08-22       Impact factor: 4.147

8.  Quality of life in women with lipoedema: a contextual behavioral approach.

Authors:  Joanna E Dudek; Wojciech Białaszek; Paweł Ostaszewski
Journal:  Qual Life Res       Date:  2015-07-28       Impact factor: 4.147

9.  Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomes.

Authors:  Sofia de Achaval; Michael A Kallen; Maureen D Mayes; Maria A Lopez-Olivo; Maria E Suarez-Almazor
Journal:  J Rheumatol       Date:  2013-06-15       Impact factor: 4.666

10.  An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility.

Authors:  Chiara M Antonioli; Giovanni Bua; Anna Frigè; Katia Prandini; Sara Radici; Mirko Scarsi; Elisabetta Danieli; Andrea Malvicini; Paolo Airo
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.